In summary, NURR1 exerts tumor-suppressive effects in neuroblastoma through multiple molecular axes: p53-mediated apoptosis, cell cycle checkpoint control, ROS regulation, and repression of pro-survival signaling pathways including PI3K/Akt, NF-κB, and MAPK/ERK. The gene discussed is TP53; the disease is neoplasm.